Andrius Žučenka, Head of The Department of Specialized Care For Immunocompromised Patients at VUL Santaros Klinikos, shared a post on X:
“Please stop by at our EHA2024 poster P1325 with the results of the non-intensive, targeted therapy-based preconditioning regimens followed by standard conditioning and alloSCT in relapsed/refractory AML/HR-MDS patients with active disease (including TP53m/post-Ven).”
Source: Andrius Žučenka/X